ArticlePloS one2026
Multi-district molecular surveillance of dengue virus in Pakistan reveals serotype cycling and recurrent DENV-2 dominance, 2021-2025.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dengue virus (DENV) remains a major public health concern in Pakistan, with recurrent seasonal outbreaks and shifting serotype patterns. Understanding temporal and geographic trends in circulating serotypes is essential for improving surveillance and outbreak preparedness. This study aimed to characterize the spatio-temporal distribution and serotype dynamics of DENV detected through molecular surveillance in Pakistan between 2021 and 2025. NS1-positive dengue cases were tested at the National Institute of Health (NIH), Islamabad, using real-time reverse transcription polymerase chain reaction (qRT-PCR) for serotyping. Demographic, temporal, and geographic data were analyzed to assess the distribution of DENV infections and circulating serotypes over the study period. Among 1,644 NS1-positive dengue cases tested, 1,162 were confirmed by qRT-PCR. DENV-2 was the predominant serotype overall, accounting for 78.4% of confirmed infections, followed by DENV-1 (21.4%) and DENV-3 (0.09%). Temporal analysis showed that DENV-2 predominated during 2021 and 2022, was temporarily replaced by DENV-1 in 2023, and re-emerged as the dominant serotype in 2024 and 2025. Dengue transmission demonstrated strong seasonal patterns, with most cases occurring during the post-monsoon months of September and October. Gender-Age distribution showed majority of cases in males (66%), particularly those aged 21-40 years. Geographically, most confirmed cases were reported from Rawalpindi and Islamabad, reflecting the primary referral catchment of the surveillance system, while additional cases were detected from several other districts, including Peshawar, Nowshera, Mansehra, and Karachi. These findings highlight dynamic shifts in DENV serotype circulation in Pakistan and emphasize the need for sustained molecular surveillance to guide public health responses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.